Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 418 (OTC: $CSUI) (TSX: $TGOD.TO) (NYSE: $APHA) (TSX: $LABS.TO) (OTC: $ERBB)
Delta, Kelowna, BC, May 27, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/05271CSUI-TGOD-APHA-LABS-ERBB.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
Today’s podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI), a research & development company licensed under Swiss Cannabis and tobacco regulations to cultivate and sell cannabis. The Company's facilities for producing cannabis are based in Zurich.
The Company grows high quality, organic cannabis with sustainable, all-natural principles. Cannabis Suisse products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product.
In today’s podcast we will be looking at a few private and public company announcements.
The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (OTC:TGODF), a leading producer of premium certified organic cannabis, announced that it has made its first shipment of Highly Dutch, TGOD's new mainstream brand designed for regular users. Starting today, Highly Dutch is available in Quebec in a one-ounce format (28 grams) of its Rotterdam OG Indica strain and will become available in additional provinces during the weeks ahead. This launch will be followed by additional Highly Dutch strains, sizes, and formats later this summer.
Recent studies indicate that daily users make up 26% of cannabis consumers in Canada and that their consumption represents approximately 90% of the total volume being sold. Highly Dutch's value proposition has been tailored specifically to meet the needs of regular users. Research has also highlighted that 30% of daily users purchase their cannabis in a one-ounce format, and 14% purchase it in a half-ounce format, which guided the brand's packaging strategy. Consumers can visit highlydutch.ca for additional information on the brand.
"Our scaled production enables us to address a larger segment of the market that prefers consuming high-quality organic cannabis. Our research also shows that value-conscious consumers prefer buying cannabis in larger volumes, which is why we are launching with Highly Dutch's one-ounce format (28 grams)," commented Brian Athaide, CEO of TGOD. "This launch is consistent with plans announced in the prospectus we filed in April and reflects our commitment to expanding our portfolio and consumer reach. Highly Dutch allows us to significantly broaden our consumer base and better leverage the significant organic cultivation infrastructure we have built while continuing to focus on the premium segment with the TGOD brand," continued Athaide.
Quebec is the first province where TGOD deploys its dual branding strategy; Highly Dutch's debut coincides with the launch of four other products from TGOD's premium brand in the province – Happy Hibiscus Maté CBD/THC (tea), Happy Hibiscus Maté THC (tea), Unite Organic dried flower, and Harmony Organic dried flower.
Known for its award-winning glass jar, TGOD started selling premium certified organic cannabis in the recreational market in August 2019 with a small pilot in Ontario at the OCS. As it ramped up its production, it gradually expanded its distribution and product offerings. Its products are now available to medical patients nationally and in recreational stores in every province except Prince Edward Island.
TGOD worked in partnership with Velvet Management Inc. on its Highly Dutch distribution strategy. Velvet is the Company's exclusive sales agent for its adult-use cannabis products in Canada.
Aphria Inc. (TSX: APHA) (NYSE: APHA), a leading global cannabis company, announced that it will transfer its stock exchange listing from the New York Stock Exchange ("NYSE") to The Nasdaq Global Select Market ("Nasdaq"), effective Friday, June 5, 2020, after the market close. The Company expects its common stock will begin trading as a Nasdaq-listed security at market open on Monday, June 8, 2020 and will continue to be listed under the ticker symbol "APHA." This transition will not impact the Company's primary listing on the Toronto Stock Exchange (TSX: APHA).
"We are excited to have Nasdaq as our new exchange partner. This move is a reflection of our ongoing commitment to find cost effective ways of operating so we can continue to deliver long-term value to shareholders," said Irwin D. Simon, Chief Executive Officer.
"Additionally, as a purpose driven Company, we believe Nasdaq will be a good fit for Aphria, particularly given our focus on, and the progress we have made, integrating ESG practices across our business."
"With over 76% of Nasdaq-listed companies reporting on at least one ESG metric, we welcome Aphria to the Nasdaq family as they strive to integrate ESG best practices across their business and add strategic value to all of their stakeholders," said Bob McCooey, Global Head of Capital Markets, Nasdaq.
The last day of trading of the Company's common stock on NYSE is expected to be Friday, June 5, 2020.
HelloMD in collaboration with Dr. Sana-Ara Ahmed announced that it is offering support to chronic pain patients in Alberta during COVID19. According to Statistics Canada, six million people suffer from chronic pain across Canada. With the current mandate for social distancing, patients across all demographics are having a difficult time finding proper medical support.
Dr. Sana-Ara Ahmed, Specialist in Interventional Chronic Pain and Cannabinoid Medicine, together with HelloMD are offering virtual access care to help chronic pain patients during this difficult time. Dr. Ahmed's knowledgeable and compassionate approach, combined with HelloMD's turnkey set of virtual care tools, are making it easier for chronic pain patients to receive therapeutic options, while staying safe at home.
"For me, my patients always come first and I am always thinking about how I can best support them", said Dr. Ahmed. "COVID19 has proved to be a challenging time, especially for my chronic pain patients, as we cannot provide in-person consultations or care. HelloMD, and the ease with which my team and patients have adapted to their virtual processes, has been invaluable in helping us quickly ramp up to support new and existing patients." She added.
Through this partnership, chronic pain patients seeking support with medical cannabis will have access to health care practitioners who can counsel and provide medical documents directly to Medical Cannabis by Shoppers, easing this aspect of the health care journey for patients.
"We offer clinics the core pieces they need now - turnkey virtual care technology, live patient support and work flows all uniquely attuned to medical cannabis - while enabling their practitioners to focus on delivering patient care", said Larry Lisser, Senior Vice President of Business Development, HelloMD. "Dr. Ahmed values offering her patients trusted sources for fulfillment, and our integration with Medical Cannabis by Shoppers ensures her patients get the access they seek, while removing this administrative burden from her clinic team", Lisser added.
"We launched Medical Cannabis by Shoppers with one purpose: to extend trusted access to the widest variety of medical cannabis products support to patients across Canada," said Ken Weisbrod, Vice President of Business Development, Shoppers Drug Mart. "Offering product fulfillment and pharmacist support to Dr. Ahmed's chronic pain patients align with this mission", Weisbrod added.
Medical Cannabis by Shoppers is Shoppers Drug Mart's online platform for the sale of medical cannabis. The service breaks down existing barriers for patients by providing convenient access to a broader range of options through a single source, alongside expert advice and counsel from trusted healthcare professionals.
To facilitate care between Dr Ahmed and her patients, HelloMD provides Genuvis Health with a dedicated website for its patients to register for an online appointment. The HelloMD team assists Dr. Ahmed's patients with onboarding, scheduling and virtually connecting with Dr Ahmed. After the consult, and patient registration with Medical Cannabis by Shoppers, virtual pharmacists are made available to assist with product purchases and fulfillment.
MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) and Argentina Gold Corporation, a Canadian vertically integrated licensed producer, announced the formation of a supply arrangement to bring premium cannabis-infused products to Atlantic Canada.
Under the agreement, which has an initial 2-year term, MediPharm Labs will provide Argentia Gold-branded formulated tincture bottles of CBD cannabis resin and Argentia Gold will provide distribution, sales, and service to leading retailers in Newfoundland and Labrador, Prince Edward Island, Nova Scotia and New Brunswick.
“We are committed to delivering the highest quality products to our customers throughout Atlantic Canada and doing so in partnership with MediPharm Labs is a virtual guarantee of success,” said Dave Thomson, President of Argentia Gold. “As our white-label supply partner, MediPharm Labs is able to address exactly what we need: reliable, responsive production that meets Good Manufacturing Practice (GMP) standards backed by some of the cannabis industry’s most knowledgeable scientists, pharmaceutical professionals and extraction specialists. Argentia Gold’s destination is market leadership and this agreement is an important milestone in our journey.”
Canadian consumption rates for cannabis are the highest per capita in Atlantic Canada (up to 26.8 percent in Nova Scotia, 25.2 per cent for Newfoundland, 23.2 per cent for Prince Edward Islandi). In comparison, the cannabis consumption rate for Ontario is up to 18.1 per centii.
“Consumers in Atlantic Canada deserve only the very best quality cannabis-infused products and that’s exactly what they will receive as a result of this exciting partnership,” said Pat McCutcheon, CEO of MediPharm Labs. “Argentia Gold is deeply invested in their community, understands the market, knows local preferences and with a trusted portfolio of premium products will no doubt grow into one of Canada’s foremost licensed producers. We are very proud to play a formative role in the next stage of their development.”
American Green (OTC: ERBB) announced today that EZ WEED has selected and purchased the company’s proprietary smart vending solution -- called the “AGM” -- as their “system of choice” for EZ Weed’s new business venture teaming up with prospective cannabis dispensaries throughout the nation.
EZ Weed is run by Managing Partner, Lauren Smee and backed by retired NFL Linebacker-turned-venture-capitalist, Lamarr Houston. Mr. Houston, who played professionally for the Oakland Raiders and Chicago Bears, recently visited American Green’s AGM facility in Gastonia, NC. According to AGM Division Head, Lindel Creed, “It was obvious to me from the minute they both arrived at the AGM facility, that both Ms. Smee and Mr. Houston knew exactly which machine features they required for their venture and, by the time they left the facility, both were convinced that American Green could provide them.”
EZ WEED expects to purchase and supply the AGM Dispensing Vending Machines following their up-and-coming EZ Weed national launch and have already begun securing their location agreements with some of the top dispensaries in the US. According to Ms. Smee, “Our partnership with American Green is vital in reaching our goal of becoming the first national and mainstream marijuana vending machine provider and service. The automation, humanless sales method, and intelligent vending capabilities of the AGM will allow us to scale for high growth.”
EZ WEED was founded in January 2020. The company came to fruition organically through a love of cannabis and Ms. Smee’s extensive knowledge in launching startups -- with a new twist and groundbreaking sales method in the cannabis industry. The average sales process in a dispensary can be anywhere from 15-45 minutes. With EZ WEED, the entire process, even as a first-time user, is on average 3 to 5 minutes.
Besides the state-of-the-art machines, EZ WEED also provides its dispensary partners with “white glove” customer service as well as completely customizable digital marketing for each American Green AGM vending machine it provides. We do all the work pertaining to custom menus, product display, machine maintenance and a dedicated account manager that remotely keeps track of machine sales and inventory.
Once again, today’s podcast was sponsored by Cannabis Suisse Corp. (OTC: CSUI), a research & development company licensed under Swiss Cannabis and tobacco regulations to cultivate and sell cannabis. The Company's facilities for producing cannabis are based in Zurich.
The Company grows high quality, organic cannabis with sustainable, all-natural principles. Cannabis Suisse products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure: CSUI is a paid monthly news and social media client More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Contact Investorideas.com
800 665 0411
